Israel's leading law firm

Recent transaction and litigation

Home > Media Center > Recent transaction and litigation > 2013 > Representation of Evogene in its $73.8 million initial public offering and listing on NYSE
2013 / November 2012

Representation of Evogene in its $73.8 million initial public offering and listing on NYSE

Join our newsletter careers Contact us